Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tarsus Pharmaceuticals, Inc.

TARS Clue Score56
United States Fiscal year ends December CIK 0001819790 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Andrew D. Goldberg
7 Mar 2025
Director
Exercised, kept
7,000
$12.89
$90.23K
Aziz Mottiwala
24 Aug 2022
Chief Commercial Officer
Exercised, kept
772
$0.45
$347.40
Aziz Mottiwala
24 Aug 2022
Chief Commercial Officer
Exercised, kept
4,416
$10.99
$48.53K
Showing 250 of 274 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 304
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 64
Sales straight out of an exercise 5
Sales at will 191
Transactions with no price 0
Shares from compensation/vesting 11,493,487
Sales filed before the plan box existed 99
History held since 20 Oct 2020